Heidelberg Pharma AG (HPHA)

BRIEF

published on 03/06/2024 at 07:51, 8 months 16 days ago

Heidelberg Pharma to Showcase HDP-101 Efficacy and ADC Technology at AACR 2024

Cancer Research Heidelberg Pharma HDP-101 ADC Technology AACR Meeting 2024
PRESS RELEASE

published on 03/06/2024 at 07:46, 8 months 16 days ago

Heidelberg Pharma to Present First Efficacy Data on HDP-101 and Data from Proprietary ADC Technology Platform at AACR Meeting 2024
Heidelberg Pharma to present first efficacy data on HDP-101 and data from proprietary ADC technology platform at AACR Meeting 2024. Details of ATAC and ADC-based cancer therapies

Clinical Trials Heidelberg Pharma ADC Technology AACR Meeting 2024 ATAC Therapies
BRIEF

published on 03/04/2024 at 11:24, 8 months 17 days ago

Heidelberg Pharma obtient jusqu'à 115 millions de dollars de financement en redevances auprès de HealthCare Royalty

Heidelberg Pharma Redevance En Matière De Soins De Santé Financement Des Redevances ZircaixTM Produits Biopharmaceutiques
BRIEF

published on 03/04/2024 at 11:24, 8 months 17 days ago

Heidelberg Pharma Secures Up to $115 Million in Royalty Financing from HealthCare Royalty

Biopharmaceuticals Heidelberg Pharma HealthCare Royalty Royalty Financing ZircaixTM
PRESS RELEASE

published on 03/04/2024 at 11:19, 8 months 17 days ago

Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million
Heidelberg Pharma announces royalty financing agreement with HealthCare Royalty for up to USD 115 million. Agreement to purchase royalties from Telix Pharmaceuticals for Zircaix(TM)

Biotech Heidelberg Pharma HealthCare Royalty Royalty Financing Zircaix
BRIEF

published on 03/04/2024 at 11:07, 8 months 17 days ago

Heidelberg Pharma conclut un accord de financement de redevances d'une valeur pouvant atteindre 115 millions de dollars avec HealthCare Royalty

Oncologie Heidelberg Pharma Zircaix Redevance En Matière De Soins De Santé Financement Des Redevances
BRIEF

published on 03/04/2024 at 11:07, 8 months 17 days ago

Heidelberg Pharma Secures Royalty Financing Deal Worth Up to $115 Million with HealthCare Royalty

Oncology Heidelberg Pharma HealthCare Royalty Royalty Financing Zircaix
PRESS RELEASE

published on 03/04/2024 at 11:02, 8 months 17 days ago

EQS-Adhoc: Heidelberg Pharma Announces Royalty Financing Agreement with HealthCare Royalty for up to USD 115 million
Heidelberg Pharma announces royalty financing agreement with HealthCare Royalty for up to USD 115 million. Agreement involves royalties from worldwide sales of Telix Pharmaceuticals' ZircaixTM

Heidelberg Pharma HealthCare Royalty Royalty Financing Telix Pharmaceuticals ZircaixTM
PRESS RELEASE

published on 11/02/2023 at 16:34, 1 year ago

Heidelberg Pharma Presents New Clinical Data from its Lead Candidate HDP-101 at the ASH Annual Meeting 2023
PRESS RELEASE

published on 10/12/2023 at 07:09, 1 year 1 month ago

Heidelberg Pharma AG: Interim Management Statement on the First Nine Months of 2023

Published on 11/22/2024 at 09:00, 26 minutes ago

Industrial Software Company mlean Celebrates 10 Years of Continuous Improvement
Published on 11/22/2024 at 00:00, 9 hours 26 minutes ago

Gratomic Announces Company and Operational Update
Published on 11/21/2024 at 22:05, 11 hours 21 minutes ago

Protagonist Announces Nomination of PN-881, a Potential Best-in-Class Oral Peptide IL-17 Antagonist Development Candidate
Published on 11/21/2024 at 21:50, 11 hours 36 minutes ago

Seventy Ninth Resources Announces Successful First Reconnaissance at McKellar Copper-Zinc and Enable Gold Projects
Published on 11/21/2024 at 20:15, 13 hours 11 minutes ago

Woodland Park Zoo Awarded Transformative Grant to Advance Empathy for Animals

View all ACCESSWIRE

Published on 11/22/2024 at 09:06, 19 minutes ago

Original-Research: NFON AG (von NuWays AG): Buy
Published on 11/22/2024 at 09:05, 20 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 11/22/2024 at 09:03, 22 minutes ago

Amundi Physical Metals plc: UK Final Terms
Published on 11/22/2024 at 09:02, 23 minutes ago

Amundi Physical Metals plc: Final Terms
Published on 11/22/2024 at 09:02, 23 minutes ago

Original-Research: Nabaltec AG (von NuWays AG): Buy

View all EQS

Published on 11/21/2024 at 06:58, 1 day 2 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 2 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/21/2024 at 06:58, 1 day 2 hours ago

Netto-actiefwaarde per aandeel stijgt in zes maanden met 9,4% tot EUR 55,6 dankzij aanhoudend sterke groeiprestaties van portefeuille
Published on 11/20/2024 at 20:07, 1 day 13 hours ago

Entech : Nouveaux objectifs stratégiques à moyen-terme et Chiffre d’Affaires du 1er semestre 2024
Published on 11/20/2024 at 19:20, 1 day 14 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting

View all LES ECHOS COMFI WIRE

News